It is therefore likely that DAC could have induced the expression of FRK without demethylating any of the CpG sites in the promoter region as was noted when the hypomethylated BT20 breast cancer cells were treated (Supplementary Figures 2 and 4). The gene discussed is FRK; the disease is breast carcinoma.